Pharmacokinetics of Anidulafungin in Obese and Normal-Weight Adults

In 2025, approximately one out of five adults will be obese. Physiological changes associated with obesity have been shown to influence the pharmacokinetics of drugs. Anidulafungin is frequently used in critically ill patients, and to achieve optimal efficacy, it is essential that its dose is approp...

Full description

Saved in:
Bibliographic Details
Published in:Antimicrob Agents Chemother
Main Authors: Wasmann, Roeland E., ter Heine, Rob, van Dongen, Eric P., Burger, David M., Lempers, Vincent J., Knibbe, Catherijne A., Brüggemann, Roger J.
Format: Artigo
Language:Inglês
Published: American Society for Microbiology 2018
Subjects:
Pharmacology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6021625/
https://ncbi.nlm.nih.gov/pubmed/29712664
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00063-18
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items